Edwards Lifesciences To Present At The Canaccord Genuity Annual Growth Conference

Aug 03, 2015, 08:48 ET from Edwards Lifesciences Corporation

IRVINE, Calif., Aug. 3, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Canaccord Genuity 35th  Annual Growth Conference at the InterContinental Boston on Wednesday, August 12, 2015.

Donald E. Bobo, Jr., CVP, Heart Valve Therapy, Strategy and Corporate Development, is scheduled to speak to conference attendees at 10:00 a.m. EDT. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com/events.cfm.  Following the presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section, and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring.  Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.  Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

Logo - http://photos.prnewswire.com/prnh/20140714/126903

SOURCE Edwards Lifesciences Corporation